<div align="center">
  <img src="images/logo.png" alt="MetaboWell Logo" width="200"/>
  
  # MetaboWell
  
  > Empowering Indians to achieve lasting weight loss through GLP-1 medications with continuous medical support, personalized nutrition, and a caring community.
</div>

## Overview

**MetaboWell** is an integrated GLP-1 weight loss care platform launching in India, targeting Tier 1 and Tier 2 cities. The platform combines teleconsultations, lab diagnostics, pharmacy coordination, dietician support, and peer community into a seamless patient journey focused on:

- **GLP-1 Medical Weight Loss** (Tirzepatide/Mounjaro, Semaglutide/Ozempic)
- **Continuous Care Coordination** (not "prescribe and abandon")
- **Nutrition & Lifestyle Guidance**
- **Long-term Metabolic Health Management**

## Vision

Create India's first integrated GLP-1 weight loss care platform that supports patients through their entire journey - from initial consultation through lifelong metabolic health maintenance - with personal touch that big platforms can't replicate.

## Core Features (Planned)

### MVP (Phase 1 - 3-6 Months)
- ðŸ‘¨â€âš•ï¸ **Doctor Marketplace** - Credible doctors (hospital-affiliated), video consultations, transparent credentials
- ðŸ“± **Patient Onboarding** - Frictionless, conversational, progressive data collection
- ðŸ“Š **Digital Health Records (EHR)** - Patient history accessible to all providers
- ðŸ’¬ **WhatsApp Support** - Critical first-month support when side effects emerge
- ðŸ“ˆ **Patient Tracking** - Weight, medication dosage, side effects, mood logging
- ðŸŽ™ï¸ **Voice-to-Text Notes** - Doctors dictate observations, auto-transcribed and filed
- ðŸ“š **Educational Content** - GLP-1 safety, obesity as disease, treatment protocols
- ðŸŽ¯ **Visual Onboarding** - Empowerment messaging ("Take control of your life")
- ðŸ”¬ **Lab Partnerships** - Home blood test integration
- ðŸ‘¥ **Peer Support Groups** - Small, curated communities (10-15 patients)

### Future Features (6-12+ Months)
- ðŸŽ® **Gamification** - Medication adherence streaks, weight loss milestones, badges
- ðŸ¤– **AI Pattern Recognition** - Predict side effects, plateaus, adherence issues
- ðŸšš **Real-time Tracking** - Lab test and medication delivery tracking
- ðŸ’Š **Pharmacy Integration** - Seamless medication fulfillment
- ðŸ¥— **Dietician Network** - Ongoing nutrition support and check-ins
- ðŸ¢ **Corporate Wellness** - B2B employer-paid programs
- ðŸŒ **Multi-language** - Regional languages for Tier 2 expansion
- ðŸ“± **Smart Scale Integration** - Auto-sync weight data

## Target Audience

### Primary (Launch Focus)
- Adults 30-55 in Tier 1 cities (Mumbai, Delhi, Bangalore)
- Obese (BMI 30+) or overweight with comorbidities
- Tried traditional weight loss (diets, gym) with rebound
- Aware of or curious about GLP-1 medications
- Budget: Can afford â‚¹6,000-20,000/month for treatment
- Digitally comfortable

### Secondary (6-12 Month Expansion)
- Adults 30-55 in Tier 2 cities
- Similar profile but need more GLP-1 education
- Price sensitivity higher (await generics)
- Regional language preference

### Tertiary (Future)
- Type 2 diabetics (GLP-1 treats diabetes too)
- Corporate wellness programs (B2B)
- Pre-diabetics (prevention vs. treatment)

### Key Partners
- RMP-certified endocrinologists/bariatric specialists
- Registered dieticians with GLP-1 experience
- Diagnostic labs (home blood test capability)
- Pharmacies or pharmaceutical manufacturers (Eli Lilly, Novo Nordisk)

## Business Model

### Primary Revenue (Launch)
- **Doctor Consultations:** â‚¹500 per consultation (Tier 2), â‚¹1,000-1,500 (Tier 1 metros)
- **Platform Subscription:** TBD - Hybrid model (pay-per-consult + subscription for platform features)
- **Dietician Services:** â‚¹500-1,000/month per patient (ongoing nutrition support)

### Secondary Revenue (Future)
- **Lab Test Bundles:** â‚¹2,500-8,000 per comprehensive panel
- **Pharmacy Commissions:** Medication fulfillment fees
- **Corporate Wellness:** B2B employer-paid programs
- **Pharma Partnerships:** Patient education programs (Eli Lilly, Novo Nordisk)

## Technology Stack

- **Platform:** Cross-platform (mobile + desktop) - React Native/Flutter for mobile, React web app
- **Video Consultation:** Twilio, Agora, or similar
- **WhatsApp Integration:** WhatsApp Business API
- **EHR Database:** DISHA-compliant cloud hosting (AWS, GCP with healthcare compliance)
- **Voice-to-Text:** Google Speech-to-Text or similar for doctor notes
- **Payment Gateway:** Razorpay, Stripe India
- **AI/ML (Future):** Pattern recognition for side effects, plateaus, adherence

## Documentation

### Strategic Planning
- [`docs/brainstorming-session-results.md`](docs/brainstorming-session-results.md) - Comprehensive strategic brainstorming session (120 min, 60+ ideas) covering platform strategy, features, partnerships, MVP scope, and risk mitigation
- [`docs/initial-thoughts.md`](docs/initial-thoughts.md) - Original concept and market opportunity

### Business Planning
- [`docs/investor-deck-enhanced-slides.md`](docs/investor-deck-enhanced-slides.md) - Investor presentation
- [`docs/unit-economics-model.md`](docs/unit-economics-model.md) - Financial modeling
- [`docs/metabowell-competitive-analysis.md`](docs/metabowell-competitive-analysis.md) - Competitive landscape
- [`docs/investor-qa-prep-guide.md`](docs/investor-qa-prep-guide.md) - Investor Q&A preparation

### Product Requirements (Coming Soon)
- Product Requirements Document (PRD)
- Technical Architecture
- User Stories & Sprint Planning

### Research & Compliance (CRITICAL - In Progress)
- ðŸš¨ Indian Telemedicine Practice Guidelines for GLP-1 prescriptions
- DISHA compliance (Digital Information Security in Healthcare Act)
- Schedule drug classification and requirements
- Market research findings (Tier 1 vs. Tier 2)

## Project Status

ðŸš§ **Current Phase:** Strategic Planning Complete â†’ Regulatory Research (BLOCKING)

### MVP Scope (8-Month Timeline)
**14 core features identified for launch:**
1. Patient onboarding (frictionless, conversational)
2. Doctor marketplace (video consultations)
3. Digital health records (EHR)
4. WhatsApp support integration
5. Patient tracking (weight, meds, side effects)
6. Doctor voice-to-text notes
7. Digital prescription system
8. Educational content library
9. Visual onboarding experience
10. Doctor credentials display
11. Lab partnerships (home blood tests)
12. Pharmacy strategy (manufacturer or network)
13. Dietician recruitment
14. Compliance framework (DISHA)

### Critical Path Items - WEEK 1
- [ ] ðŸš¨ **REGULATORY RESEARCH** (BLOCKING EVERYTHING) - Engage healthcare lawyer for telemedicine guidelines
- [ ] Initial market validation (5-10 patient conversations)
- [ ] Doctor recruitment preparation (list 20-30 targets)
- [ ] Competitive intelligence (1mg, Practo, hospital programs)
- [ ] Financial modeling (unit economics, funding needs)

## Competitive Advantage

- **Continuous Care Model** - Fills massive gap where Indian healthcare abandons patients after prescription
- **Personal Touch at Scale** - High-touch service (same doctor, success coaches, personal milestones) that big platforms can't replicate
- **Integrated Ecosystem** - Doctors + Labs + Pharmacy + Dieticians + Community in ONE coordinated experience
- **Community as Retention Driver** - Sense of belonging, peer support, lifelong relationships (3-5 year LTV)
- **Lifelong Patient Relationships** - Medical reality (weight rebound) + platform stickiness = long-term retention
- **First-Mover in Category** - GLP-1 in India is nascent, opportunity to establish standards

## Market Opportunity

- **Current Market:** Mounjaro became 2nd highest-selling branded drug in India (August 2025)
- **Market Expansion:** Generic semaglutide (Wegovy/Ozempic) patents expire 2026 - Indian pharma will flood market
- **Tier 1 Cities:** Early adopters, awareness high, willing to pay premium (launch focus)
- **Tier 2 Cities:** 10x market size of Tier 1, will drive volume as generics arrive and awareness spreads
- **Total Addressable Market:** Adults 30-65 struggling with obesity across India (300M+ potential patients)
- **Perfect Timing:** Eli Lilly investing $1 billion in India plant, GLP-1 medications about to become widely available and affordable

## Key Differentiators vs. Hospital Programs

| Feature | MetaboWell | Traditional Hospitals |
|---------|------------|----------------------|
| **Care Model** | Continuous support (3-5 years) | Episodic care (prescribe & abandon) |
| **Convenience** | Video consultations, no travel | Requires hospital visits |
| **Support** | WhatsApp access, peer groups, dietician | Limited follow-up |
| **Integration** | All services coordinated | Fragmented departments |
| **Cost** | â‚¹500-1,500 per consult | â‚¹1,000-3,000 per visit + travel |
| **Personal Touch** | Same doctor, personalized care | Different doctors each visit |
| **Time Savings** | Zero travel time | Hours spent traveling to hospital |

## Getting Started

### For Contributors
> This project is currently in strategic planning phase. Development setup instructions will be added once technical architecture is finalized.

### For Stakeholders
Review the comprehensive brainstorming session results in `docs/brainstorming-session-results.md` for full strategic context.

## Roadmap

### Phase 1: Regulatory Research & Strategy (Months 1-2)
- [x] Strategic brainstorming and planning (120 min session, 60+ ideas)
- [ ] ðŸš¨ **CRITICAL:** Engage healthcare regulatory lawyer for telemedicine guidelines
- [ ] Determine GLP-1 Schedule classification and prescription requirements
- [ ] Finalize business model (pure digital vs. hybrid with in-person first visit)
- [ ] Initial doctor, lab, pharmacy, dietician partnership discussions
- [ ] DISHA & data privacy compliance review

### Phase 2: Partnership Development (Months 2-3)
- [ ] Recruit 3-5 pilot doctors (endocrinologists, bariatric specialists)
- [ ] Lab partnership (1-2 labs for home blood tests)
- [ ] Pharmacy strategy decision (Eli Lilly direct vs. pharmacy network)
- [ ] Recruit 3-5 dieticians
- [ ] University/research partnership for credibility

### Phase 3: Platform Development (Months 3-5)
- [ ] Core architecture: Onboarding, doctor marketplace, video consultation
- [ ] EHR system, patient tracking, WhatsApp integration
- [ ] Doctor voice-to-text notes, educational content CMS
- [ ] Payment integration, prescription workflows
- [ ] Visual onboarding experience, educational content creation

### Phase 4: Beta Testing (Month 6)
- [ ] Recruit 20-50 beta patients (personal networks, doctor referrals)
- [ ] Test all user flows and gather systematic feedback
- [ ] Success metrics: 70%+ onboarding completion, <5% technical issues, 4+ star satisfaction

### Phase 5: Iteration (Month 7)
- [ ] Fix critical issues from beta
- [ ] Refine onboarding flow, improve doctor tools
- [ ] Content additions based on patient questions
- [ ] Prepare launch marketing

### Phase 6: Public Launch (Month 8)
- [ ] Launch in 2-3 Tier 1 cities (Mumbai, Delhi, Bangalore)
- [ ] "Do things that don't scale" acquisition (gyms, events, personal outreach)
- [ ] Goal: 100 paying patients in first 3 months
- [ ] Capture success stories for scalable marketing

### Phase 7: Scale (Months 9-12)
- [ ] Tier 2 city expansion as awareness grows
- [ ] Gamification, AI pattern recognition features
- [ ] Corporate wellness pilots
- [ ] Pharmacy integration optimization

## Contact & Team

> Team information and contact details will be added as the project progresses.

## License

> License information to be determined.

---

## Core Values

**Continuous Care** - Never abandon patients after prescription - support through entire journey  
**Personal Touch** - Every patient known by name, not treated as transaction  
**Integration** - Seamless coordination across doctors, labs, pharmacy, dieticians, community  
**Results-Driven** - Focus on lasting weight loss and metabolic health, not quick fixes  
**Education-First** - Convince through science, not hype  
**Trust** - Evidence-based care with credible doctors, transparent compliance  
**Community** - Sense of belonging that transforms service into lifestyle  

---

**MetaboWell** - *Stop the yo-yo diet cycle. Science-backed GLP-1 weight loss with continuous support you can trust.*

